SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-12-001736
Filing Date
2012-01-11
Accepted
2012-01-10 19:10:26
Documents
1
Group Members
MICHAEL S. WEISS

Document Format Files

Seq Description Document Type Size
1 v245185_sc13da.htm SC 13D/A 87405
  Complete submission text file 0001144204-12-001736.txt   89169
Mailing Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019
Business Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019 (212) 582-3950
MANHATTAN PHARMACEUTICALS INC (Subject) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-51051 | Film No.: 12520900
SIC: 2834 Pharmaceutical Preparations

Mailing Address 787 7TH AVENUE 48TH FLOOR NEW YORK NY 10019
Business Address 787 7TH AVENUE 48TH FLOOR NEW YORK NY 10019 212-554-4504
Opus Point Partners, LLC (Filed by) CIK: 0001503454 (see all company filings)

IRS No.: 262737756 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A